Citigroup Inc. Has $16.17 Million Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Citigroup Inc. increased its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 27.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 516,680 shares of the company's stock after purchasing an additional 110,012 shares during the period. Citigroup Inc. owned 0.30% of Option Care Health worth $16,172,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD boosted its holdings in shares of Option Care Health by 1.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,760,482 shares of the company's stock valued at $59,047,000 after acquiring an additional 23,676 shares during the period. Janus Henderson Group PLC increased its stake in shares of Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company's stock valued at $7,617,000 after purchasing an additional 146,837 shares during the period. Tidal Investments LLC raised its holdings in shares of Option Care Health by 74.2% during the first quarter. Tidal Investments LLC now owns 13,460 shares of the company's stock valued at $451,000 after buying an additional 5,733 shares during the last quarter. Harbor Capital Advisors Inc. boosted its position in shares of Option Care Health by 317.9% during the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company's stock worth $2,670,000 after buying an additional 73,312 shares during the period. Finally, SG Americas Securities LLC grew its holdings in Option Care Health by 619.3% in the 2nd quarter. SG Americas Securities LLC now owns 60,356 shares of the company's stock worth $1,672,000 after buying an additional 51,965 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Trading Up 0.1 %

NASDAQ OPCH traded up $0.02 on Thursday, hitting $23.76. 3,574,851 shares of the stock were exchanged, compared to its average volume of 1,553,206. The company's 50-day moving average price is $27.00 and its two-hundred day moving average price is $28.93. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of 19.97, a P/E/G ratio of 2.42 and a beta of 1.32. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on OPCH. Truist Financial lowered their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a report on Friday, November 1st. Jefferies Financial Group cut shares of Option Care Health from a "buy" rating to a "hold" rating and dropped their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America downgraded Option Care Health from a "buy" rating to a "neutral" rating and cut their price objective for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, JMP Securities lifted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a report on Monday, September 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.